Literature DB >> 17373142

Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.

Joseph Bikowski1, Braham Shroot.   

Abstract

Multivesicular emulsion systems are a new patented technology for topical delivery of pharmaceutical and over-the-counter actives. This novel technology involves the creation of a 2-phase, oil-in-water emulsion system that produces concentric multilamellar spheres of oil and water. Active ingredients can be released from their respective layers upon application to the skin. In addition to a controlled-release of active agents, the multivesicular emulsion base improves the biophysical properties of the skin by reducing transepidermal water loss and enhancing skin hydration. This technology has been applied to 6% salicylic acid formulations that in clinical experience show efficacy with high tolerance in several hyperkeratotic disorders. Subjects' self-assessment was clearly indicative of the excellent cosmetic elegance of the multivesicular emulsion system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17373142

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  3 in total

Review 1.  Multivesicular Emulsion Ceramide-containing Moisturizers: An Evaluation of Their Role in the Management of Common Skin Disorders.

Authors:  Joshua A Zeichner; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2016-12-01

2.  Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema-prone skin.

Authors:  Simon G Danby; Paul V Andrew; Linda J Kay; Abigail Pinnock; John Chittock; Kirsty Brown; Samuel F Williams; Michael J Cork
Journal:  Br J Dermatol       Date:  2022-04-03       Impact factor: 11.113

3.  An Investigation of the Skin Barrier Restoring Effects of a Cream and Lotion Containing Ceramides in a Multi-vesicular Emulsion in People with Dry, Eczema-Prone, Skin: The RESTORE Study Phase 1.

Authors:  Simon G Danby; Paul V Andrew; Kirsty Brown; John Chittock; Linda J Kay; Michael J Cork
Journal:  Dermatol Ther (Heidelb)       Date:  2020-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.